Ali­gos cuts an­oth­er 10% of its work­force in repri­or­i­ti­za­tion for NASH and Covid pipelines

NASH and Covid-fo­cused Ali­gos Ther­a­peu­tics an­nounced that it is re­or­ga­niz­ing its pipeline and cut­ting around 10% of its staff to ex­tend its cash re­sources through the end of 2024.

In all, there’s been a 25% re­duc­tion in the over­all work­force at Ali­gos since the be­gin­ning of 2022, ac­cord­ing to the com­pa­ny. As of Sept. 30, 2022, Ali­gos had 89 full-time em­ploy­ees, in­clud­ing 72 em­ploy­ees in re­search and de­vel­op­ment, ac­cord­ing to SEC fil­ings.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER